Twist Bioscience Corp (TWST) — Financial Flexibility Index
Twist Bioscience Corp (TWST) has a Financial Flexibility Index of -0.04x as of March 2026. Free cash flow of $-9.57 Million (operating CF $-17.56 Million minus capex $7.99 Million) represents 0% of total liabilities ($221.12 Million). Also explore Twist Bioscience Corp equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Twist Bioscience Corp Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Twist Bioscience Corp across 10 annual periods. Check Twist Bioscience Corp PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Twist Bioscience Corp (2016–2025)
Year-by-year free cash flow to debt coverage for Twist Bioscience Corp. For the full company profile including market capitalisation, see TWST market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-19.62 Million | $-47.63 Million | $168.90 Million | ▲ +72.1% |
| 2024 | -0.42x | $-59.02 Million | $-64.09 Million | $141.63 Million | ▲ +44.4% |
| 2023 | -0.75x | $-114.69 Million | $-142.47 Million | $152.97 Million | ▼ -472.4% |
| 2022 | -0.13x | $-22.53 Million | $-124.39 Million | $171.99 Million | ▲ +81.4% |
| 2021 | -0.70x | $-85.18 Million | $-112.24 Million | $121.28 Million | ▲ +66.8% |
| 2020 | -2.11x | $-132.39 Million | $-142.25 Million | $62.62 Million | ▼ -0.9% |
| 2019 | -2.10x | $-73.18 Million | $-87.94 Million | $34.91 Million | ▼ -964.3% |
| 2018 | -0.20x | $-62.48 Million | $-66.16 Million | $317.21 Million | ▲ +3.5% |
| 2017 | -0.20x | $-44.71 Million | $-51.30 Million | $219.01 Million | ▲ +3.4% |
| 2016 | -0.21x | $-32.36 Million | $-38.59 Million | $153.07 Million | — |